1-4 of 4
Claude Negrier, MD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Fitusiran, an RNAi Therapeutic Targeting Antithrombin to Restore Hemostatic Balance in Patients with Hemophilia a or B with or without Inhibitors: Management of Acute Bleeding Events

Steven Pipe, MD, Margaret V. Ragni, MD MPH, Claude Négrier, MD PhD, Qifeng Yu, PhD, Naghmana Bajwa, MD, John Caminis, MD, Baisong Mei, MD PhD, Shauna R. Andersson, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1138.
https://doi.org/10.1182/blood-2019-124108
Published: 2019
Journal Articles

The Challenge of Myeloma-Related Thromboembolic Disease: Can Thrombin Generation Assay May Detect Disease-Related Hypercoagulability?

Yesim G. Dargaud, MDPhD, Marc Fouassier, MD, Sophie Ducastelle, MD, Philippe Moreau, MD, Charles Dumontet, MD PhD, Mauricette Michallet, MD PhD, Jean-Claude Bordet, Claude Negrier, MD PhD
Journal: Blood
Blood (2014) 124 (21): 2037.
https://doi.org/10.1182/blood.V124.21.2037.2037
Published: 2014
Journal Articles

Inactivation-Resistant Recombinant Factor VIII Exhibits Superior Thrombin Generation Capacity in Comparison to Wild-Type and B Domain-Deleted Factor VIII.

Joshua Russell, Yesim Dargaud, MD, Randal J. Kaufman, PhD, Claude Negrier, MD, PhD, Steven W. Pipe, MD
Journal: Blood
Blood (2006) 108 (11): 1604.
https://doi.org/10.1182/blood.V108.11.1604.1604
Published: 2006
Journal Articles

Generation of Factor VIII Molecules Partially Resistant to Activated Protein C.

Veronique Rolli, Ph D, Nathalie Enjolras, PhD, Cecile Ducasse, Marie-Helene Rodriguez, PhD, Thomas Weimer, PhD, Hans-Peter Hauser, PhD, Claude Negrier, MD, PhD, Jean-Luc Plantier, Ph D
Journal: Blood
Blood (2004) 104 (11): 1729.
https://doi.org/10.1182/blood.V104.11.1729.1729
Published: 2004